Janux Therapeutics (JANX) PT Lowered to $150 at Cantor Fitzgerald
Tweet Send to a Friend
Cantor Fitzgerald analyst Josh Schimmer lowered the price target on Janux Therapeutics (NASDAQ: JANX) to $150.00 (from $200.00) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
